The present invention provides taxanes compounds with a formula (I) or formula (II) structure, a method for preparing the compounds, and the compound, and uses of medicinal salts thereof and solvates used as compositions of active ingredients in the preparation of oral antitumor medicaments. In formula (I), R1 is -COR6, -COOR6, or -CONR7aR7b； R2 is C1-C6 alkyl, C1-C6 alkenyl, substitution hydrocarbyl, heterocyclic radical, aromatic group or substitute aromatic nucleus； R3 is -OR6, -OCOOR6, -OCOSR6, or -OCONR7aR7b； R4 is -OR6, -OCOOR6, -OCOSR6, -OCONR7aR7b, or H； R6 is C1-C6 alkyl, C1-C6 alkenyl, C1-C6 alkynyl, substitution hydrocarbyl, aromatic group or heterocyclic radical； R7a, R7b is hydrogen, hydrocarbyl, substitution hydrocarbyl or heterocyclic radical. In formula (II), R1 is -COR6, or -COOR6； R2 is aromatic group； R3 is -OR6； and R6 is C1-C6 alkyl, C1-C6 alkenyl, C1-C6 alkynyl, substitution hydrocarbyl, aromatic group or heterocyclic radical.
